Change of Nominated Adviser

21 Aug 2007 17:07

Akers Biosciences, Inc.21 August 2007 Akers Biosciences, Inc. ("Akers Biosciences" or "ABI") CHANGE OF NOMINATED ADVISER AND BROKER Following completion of the acquisition of Bridgewell Group Plc, ABI's existingNominated Adviser and Broker, by Landsbanki Islands hf, ABI is pleased toannounce the appointment of Landsbanki Securities (UK) Limited as NominatedAdviser and Broker with immediate effect. For further information please contact: Enquiries: Thomas A. Nicolette, President & CFO Akers Biosciences, Inc. Tel. 001 856 848 8698 This information is provided by RNS The company news service from the London Stock Exchange